# Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/molecular-targets-for-emerging-anti-tumor-therapies-for-neurofibromatosis-type-1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | J.T. Dilworth,Janice M. Kraniak,Jonathan W. Wojtkowiak,Richard A. Gibbs,Richard F. Borch,Michael A. Tainsky,John J. Reiners,Raymond R. Mattingly |
| Citations | 39 |
| DOI | 10.1016/j.bcp.2006.04.010 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2085190470 |
| PMID | 16797490 |
| Type | article |
| Year | 2006 |

## Paper authors

- [J.T. Dilworth](https://scholariq.org/researchers/j-t-dilworth/)

## Paper journal

- [Biochemical Pharmacology](https://scholariq.org/journals/biochemical-pharmacology/)

## Paper primary topic

- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)

## Paper topics

- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.